Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00840437 · ClinicalTrials.gov registry record
Quality of Life in Patients With Refractory Angina
A clinical trial, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- 90
- Enrollment target
NCT00840437: Completed study, sponsored by Minneapolis Heart Institute Foundation.
NCT00840437 is a clinical trial that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00840437 has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The health and well being of patients with refractory angina will be assessed using validated questionnaires (SF-36 and Seattle Angina Questionnaire \[SAQ\]) at baseline and one year.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-12 |
What the finished NCT00840437 record still lists
NCT00840437 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00840437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00840437 about?
NCT00840437 is a clinical study titled "Quality of Life in Patients With Refractory Angina". The health and well being of patients with refractory angina will be assessed using validated questionnaires (SF-36 and Seattle Angina Questionnaire \[SAQ\]) at baseline and one year.
What is the current status of trial NCT00840437?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2008-12. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT00840437?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia